Iqvia Holdings Inc (IQV) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iqvia Holdings Inc   (NYSE: IQV)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Iqvia Holdings Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iqvia Holdings Inc's ROI in the third quarter of 2026?
Iqvia Holdings Inc achieved a return on average invested assets (ROI) of 6.09 % in its third quarter of 2026, which is below Iqvia Holdings Inc's average return on investment, which stands at 7.47%.

ROI has improved compared to 6.03% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 75 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1288, from total ROI ranking in the second quarter of 2026 at 1495.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 4.42 % 6.88 % 13.76 % 14.5 % 9.28 %
Y / Y Net Income Change TTM 8.64 % 11.32 % 42.84 % 88.5 % 350.53 %
Investment (TTM) in Millions 22,828 21,196 23,735 23,851 22,507
Return On Investment (TTM) 6.09 % 6.03 % 5.95 % 5.94 % 5.85 %
IQV's Overall Ranking # 1288 # 1495 # 1196 # 1183 # 1117
Seq. Investment Change TTM 0.35 % -2.14 % 1.79 % 4.46 % 2.72 %
Seq. Net Income Change TTM 1.31 % -0.72 % 1.91 % 6 % 3.8 %
Net Income (TTM) in Millions 1,395 1,377 1,387 1,361 1,284

IQV Company Profile >> Back to IQV Roi Comparisons >> See Annual IQV Return On Investment



Return On Investment IQV's Ranking
Within: No.
Industry # 6
Sector # 76
Overall # 1288

Return On Investment Statistics
High Average Low
20.89 %
7.47 %
0.38 %
(Dec 31 2014)   (Sep 30 2017)







Financial Statements
Iqvia Holdings Inc's III. Quarter Investments $ 22,828 Millions IQV's Balance sheet
Iqvia Holdings Inc's III. Quarter Income $ 350 Millions Quarterly IQV's Income Statement
IQV's Income by Division See IQV's Income by Division


IQV Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 21,733 19,942 20,190 19,759 19,448
Y / Y Investment Growth 8.98 % -1.23 % 2.18 % 1.6 % -4.13 %
Net Income in Millions 1,361 1,373 1,358 1,091 971
Y / Y Net Income Growth -0.87 % 1.1 % 24.47 % 12.36 % 215.26 %
Annual Return On Investment 6.26 % 6.88 % 6.73 % 5.52 % 4.99 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 6.26 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IQV's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IQV's Competitors
Subscribers only: Roi for Iqvia Holdings Inc's Suppliers
Subscribers only: Return On Investment for IQV's Customers

Other Ratios
IQV's Roa IQV's Inventory Turnover Ratio IQV's Growth Rates IQV's Dividend Statistics
IQV's Profitability Ratios IQV's Asset Turnover Ratio IQV's Dividend Growth
IQV's Roe IQV's Valuation Ratios IQV's Financial Strength Ratios IQV's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %

Date modified: 2026-10-28T09:25:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.